Place
To
Work® Certified SEP 2026-SEP 2027 INDIA
Since 1983
A Legacy of Quality and Growth
Since 1983
Kwality Pharmaceuticals Ltd. : A Legacy of Quality and Growth
For over 40 years, Kwality Pharmaceuticals Ltd. has been a trusted name in the healthcare sector, synonymous with unparalleled growth and absolute reliability. We are driven by a customer-centric vision, committed to delivering high-quality products and services that maximize value for our valued customers.
Our journey began in 1983 with a modest venture into finished pharmaceuticals. Under the leadership of our Chairman Mr. Ramesh Arora, we secured our first drug license. Kwality Pharmaceuticals Ltd. has established itself as a leading manufacturer and exporter of pharmaceutical formulations.
-
1983Established
-
40+ Yearsof Experience
-
GlobalMarket Presence
-
Quality-LedManufacturing
A Decade of Growth
Our Company has experienced a remarkable trajectory of growth and expansion over the past six years. This growth has been fueled by a strategic focus on innovation, regulatory compliance, and global market penetration.
Key Milestones and Achievements
Innovation | Expansion | Impact-
2016
A New ChapterSuccessful listing on the BSE SME exchange marked a significant milestone in our journey.
-
2017-2021
Building Capabilities A period of rapid expansion, characterized by:- Upgrades to manufacturing facilities, including the Generic Block and Oncology Unit.
- Gaining of regulatory approvals from key global markets (Rest of the World).
- Commissioning of new production lines for Cephalosporins and Beta lactams.
- Development of innovative platform technologies and complex injectable products.
-
2022-2025
Expanding Globally A focus on global reach and product diversification:- Received approval of EU GMP and PIC/S GMP certifications with many others.
- Establishment of a Biological Unit and development of innovative products.
- Expansion into new markets, including the EU, South Africa, Brazil, and Russia/CIS.
-
2026-2027
The Next Phase DSIR Recognition for Kwality Pharmaceuticals Ltd. "Innovation Centre".- Construction of Hormonal Facilities (commencement by QI 2027).
- 100 plus product approvals across market with approvals in SRA market.
- EU-GMP approvals for oral solids, general injectables and beta-lactam units.
Product Filing & Approval
Our product filing & market approvals have mirrored our operational growth, with a steady increase over the past few years.
Possibilities
Together
Product approvals across market
Quality you can trust
